ERİŞKİN AKUT LENFOBLASTİK LÖSEMİLİ OLGULARDA YOĞUN İNDÜKSİYON KEMOTERAPİSİ SONUÇLARI

Cilt: 39 Sayı: 2 1 Haziran 2000
  • Murat Tombuloğlu
  • Seçkin Çağırgan
Ege Tıp Dergisi Kapak
Ege Tıp Dergisi
PDF İndir
EN TR

THE RESULTS OF INTENSIVE INDUCTION CHEMOTHERAPY İN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Abstract

In the last 15 years several studies have shovved that most of the patients with acute lymphoblastic leukemia can achieve complete remission by intensive induction chemotherapy. In this study we retrospectively investigated the results of the treatment of 19 adult patients with acute lymphoblastic leukemia treated by intensive induction chemotherapy. The results were compared with the 23 patients who were given less intensive induction chemotherapy during the same period. In the intensive chemotherapy group the remission rate was 84.2 %. After 61 months of follow-up, the median remission duration was 48 months and overall survival was 24 months. In control group, remission rate was 60.8 %, remission duration 6 months and total survival was 9 months. There was no early mortality detected due to intensive induction chemotherapy although ali the patients had febrile neutropenic attacks during the treatment period. In conclusion intensive induction chemotherapy car significantly increase the rate and duration of remission even though it does not have any effect on early mortality rates.

Keywords

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Murat Tombuloğlu

Seçkin Çağırgan

Yayımlanma Tarihi

1 Haziran 2000

Gönderilme Tarihi

1 Haziran 2000

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2000 Cilt: 39 Sayı: 2

IZ

https://izlik.org/JA95ZZ32DU

Kaynak Göster

RIS / Bibtex
Vancouver
1.Murat Tombuloğlu, Seçkin Çağırgan. ERİŞKİN AKUT LENFOBLASTİK LÖSEMİLİ OLGULARDA YOĞUN İNDÜKSİYON KEMOTERAPİSİ SONUÇLARI. ETD [Internet]. 01 Haziran 2000;39(2):113-5. Erişim adresi: https://izlik.org/JA95ZZ32DU

Ege Tıp Dergisi, makalelerin Atıf-Gayri Ticari-Aynı Lisansla Paylaş 4.0 Uluslararası (CC BY-NC-SA 4.0) lisansına uygun bir şekilde paylaşılmasına izin verir.